IDEXX Laboratories Inc (IDXX)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $55.48B
Last updated: Nov 17, 2026 at 11:06 AM ET
IDEXX Laboratories Inc (IDXX) P/E Ratio & Valuation History
IDEXX Laboratories (IDXX) trades at 47.3x trailing earnings and 11.8x sales. Its P/E of 47.3x is below its 5-year median of 47.6x. Its forward P/E is 41.5x. The median P/E across 11 similar companies is 27.6x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 14.0% higher over the next year. Its free cash flow yield is 2.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 47.3x |
| Forward P/E | 41.5x |
| Price to sales | 11.8x |
| Price to book | 29.5x |
| EV/EBITDA | 33.6x |
| Price to FCF | 42.4x |
| EV/FCF | 42.9x |
| PEG | 3.3 |
| FCF yield | 2.4% |
Historical Medians
Against its 10-year medians, its P/E is 11.4% below 53.4x and its P/S is 16.8% above 10.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 47.3x | 47.6x | 53.4x |
| P/S | 11.8x | 10.8x | 10.1x |
| P/B | 29.5x | 31.8x | N/A |
Valuation History
Over the 10 year ends shown, its P/E ranged from 36.8x in 2024 to 77.4x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $676.53 | 51.8x | 12.7x | 34.0x |
| 2024 | $413.44 | 36.8x | 8.8x | 21.5x |
| 2023 | $555.05 | 55.1x | 12.6x | 31.4x |
| 2022 | $407.96 | 50.8x | 10.2x | 56.2x |
| 2021 | $658.46 | 76.5x | 17.5x | 82.2x |
| 2020 | $499.87 | 77.4x | 15.8x | 68.7x |
| 2019 | $261.13 | 53.5x | 9.4x | 128.3x |
| 2018 | $186.02 | 43.6x | 7.3x | N/A |
| 2017 | $156.38 | 47.7x | 7.0x | N/A |
| 2016 | $117.27 | 47.9x | 5.9x | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IDXX
What is IDXX's forward P/E ratio?
IDEXX Laboratories has a forward P/E ratio of 41.5x.
Is IDXX stock overvalued?
GNG's valuation label for IDXX is Undervalued. Its P/E of 47.3x compares with a median of 27.6x across 11 similar companies.
What is IDXX's price to sales ratio?
IDEXX Laboratories has a price to sales ratio of 11.8x.
What is IDEXX Laboratories's average P/E ratio over 5 years?
IDEXX Laboratories's median P/E over the last 5 years is 47.6x, from 60 month-end values through Oct 2026.
What is IDXX's PEG ratio?
IDEXX Laboratories has a PEG ratio of 3.3.
IDXX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts